PGNY - Progyny, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
New York,
United States
Type: Equity
PGNY price evolution
PGNY
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.3 | $158.07 | $170.57 | $155.32 |
| Short term investments | $273.79 | $177.48 | $111.92 | $52.57 |
| Net receivables | $241.87 | $268.77 | $264.96 | $313.25 |
| Inventory | ||||
| Total current assets | $640.41 | $611.27 | $561.13 | $527.08 |
| Long term investments | ||||
| Property, plant & equipment | $27.82 | $27.74 | $27.95 | $27.75 |
| Goodwill & intangible assets | $11.88 | $11.88 | $11.88 | $11.88 |
| Total noncurrent assets | $116.21 | $115.24 | $120.41 | $122.64 |
| Total investments | $273.79 | $177.48 | $111.92 | $52.57 |
| Total assets | $756.62 | $726.51 | $681.54 | $649.72 |
| Current liabilities | ||||
| Accounts payable | $125.43 | $132.04 | $130.16 | $145.62 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $185.95 | $193.42 | $193.9 | $206.87 |
| Long term debt | $17.24 | $17.7 | $18.14 | $18.46 |
| Total noncurrent liabilities | $17.24 | $17.7 | $18.14 | $18.46 |
| Total debt | $17.24 | $17.7 | $18.14 | $18.46 |
| Total liabilities | $203.19 | $211.12 | $212.04 | $225.32 |
| Shareholders' equity | ||||
| Retained earnings | $89.97 | $76.5 | $60.6 | $45.61 |
| Other shareholder equity | $2.82 | $1.85 | $1.08 | $0.72 |
| Total shareholder equity | $553.43 | $515.39 | $469.5 | $424.4 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.3 | $120.08 | $91.41 | $70.31 |
| Short term investments | $273.79 | $69.22 | $28 | $38.99 |
| Net receivables | $241.87 | $240.07 | $134.56 | $75.66 |
| Inventory | ||||
| Total current assets | $640.41 | $433.86 | $258.54 | $190.22 |
| Long term investments | ||||
| Property, plant & equipment | $27.82 | $15.27 | $12.83 | $12.07 |
| Goodwill & intangible assets | $11.88 | $11.98 | $12.48 | $13.09 |
| Total noncurrent assets | $116.21 | $109.13 | $99.53 | $63.7 |
| Total investments | $273.79 | $69.22 | $28 | $38.99 |
| Total assets | $756.62 | $542.99 | $358.06 | $253.93 |
| Current liabilities | ||||
| Accounts payable | $125.43 | $109.29 | $61.4 | $43.51 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $185.95 | $159.54 | $98.82 | $77.79 |
| Long term debt | $17.24 | $6.48 | $7.42 | $8.32 |
| Total noncurrent liabilities | $17.24 | $6.48 | $7.42 | $9.19 |
| Total debt | $17.24 | $6.48 | $7.42 | $8.32 |
| Total liabilities | $203.19 | $166.02 | $106.24 | $86.98 |
| Shareholders' equity | ||||
| Retained earnings | $89.97 | $27.93 | -$2.42 | -$68.19 |
| Other shareholder equity | $2.82 | $0.5 | -$0.09 | $0 |
| Total shareholder equity | $553.43 | $376.97 | $251.82 | $166.95 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $269.94 | $280.89 | $279.37 | $258.39 |
| Cost of revenue | $213.05 | $218.27 | $218.73 | $199.75 |
| Gross Profit | $56.89 | $62.62 | $60.64 | $58.64 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $43.09 | $44.44 | $45.46 | $43.63 |
| Total operating expenses | $43.09 | $44.44 | $45.46 | $43.63 |
| Operating income | $13.8 | $18.19 | $15.18 | $15.01 |
| Income from continuing operations | ||||
| EBIT | $15.52 | $19.9 | $16.46 | $15.51 |
| Income tax expense | $2.79 | $5.03 | $2.18 | -$1.35 |
| Interest expense | -$0.74 | -$1.03 | -$0.71 | -$0.82 |
| Net income | ||||
| Net income | $13.47 | $15.9 | $14.99 | $17.68 |
| Income (for common shares) | $13.47 | $15.9 | $14.99 | $17.68 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1088.6 | $786.91 | $500.62 | $344.86 |
| Cost of revenue | $849.8 | $619.59 | $388.49 | $274.8 |
| Gross Profit | $238.8 | $167.32 | $112.14 | $70.06 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $176.62 | $143.98 | $79.8 | $61.71 |
| Total operating expenses | $176.62 | $143.98 | $79.8 | $61.71 |
| Operating income | $62.18 | $23.34 | $32.34 | $8.35 |
| Income from continuing operations | ||||
| EBIT | $67.39 | $23.63 | $31.97 | $8.56 |
| Income tax expense | $8.65 | -$5.92 | -$33.33 | -$37.78 |
| Interest expense | -$3.3 | -$0.81 | -$0.46 | -$0.12 |
| Net income | ||||
| Net income | $62.04 | $30.36 | $65.77 | $46.46 |
| Income (for common shares) | $62.04 | $30.36 | $65.77 | $46.46 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $13.47 | $15.9 | $14.99 | $17.68 |
| Operating activities | ||||
| Depreciation | $0.63 | $0.58 | $0.53 | $0.54 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $28.8 | $31.25 | $31.75 | $30.81 |
| Total cash flows from operations | $37.66 | $54.18 | $76.01 | $20.96 |
| Investing activities | ||||
| Capital expenditures | -$0.68 | -$0.95 | -$0.76 | -$1.25 |
| Investments | -$92.73 | -$63.36 | -$58.16 | $17.38 |
| Total cash flows from investing | -$93.41 | -$64.31 | -$58.92 | $16.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.67 | $0.72 | $1.77 | $1.97 |
| Net borrowings | ||||
| Total cash flows from financing | -$5.03 | -$2.36 | -$1.84 | -$1.85 |
| Effect of exchange rate | $0 | |||
| Change in cash and equivalents | -$60.78 | -$12.49 | $15.25 | $35.24 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $62.04 | $30.36 | $65.77 | $46.46 |
| Operating activities | ||||
| Depreciation | $2.28 | $1.6 | $1.3 | $1.91 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $122.61 | $100.75 | $33.71 | $12.82 |
| Total cash flows from operations | $188.81 | $80.39 | $26.04 | $36.2 |
| Investing activities | ||||
| Capital expenditures | -$3.64 | -$3.24 | -$2.13 | -$1.04 |
| Investments | -$196.88 | -$40.63 | $10.89 | -$38.99 |
| Total cash flows from investing | -$200.53 | -$43.87 | $8.77 | -$40.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.13 | $4.22 | $4.27 | $2.68 |
| Net borrowings | ||||
| Total cash flows from financing | -$11.07 | -$7.86 | -$13.7 | -$6.25 |
| Effect of exchange rate | $0 | |||
| Change in cash and equivalents | -$22.78 | $28.66 | $21.11 | -$10.08 |
News
Fundamentals
| Market cap | $3.14B |
|---|---|
| Enterprise value | $3.06B |
| Shares outstanding | 96.35M |
| Revenue | $1.09B |
|---|---|
| EBITDA | $69.67M |
| EBIT | $67.39M |
| Net Income | $62.04M |
| Revenue Q/Q | 25.95% |
| Revenue Y/Y | 38.34% |
| P/E ratio | 50.63 |
|---|---|
| EV/Sales | 2.81 |
| EV/EBITDA | 43.94 |
| EV/EBIT | 45.42 |
| P/S ratio | 2.89 |
| P/B ratio | 5.70 |
| Book/Share | 5.71 |
| Cash/Share | 1.01 |
| EPS | $0.64 |
|---|---|
| ROA | 8.82% |
| ROE | 12.64% |
| Debt/Equity | 0.37 |
|---|---|
| Net debt/EBITDA | 1.52 |
| Current ratio | 3.44 |
| Quick ratio | 3.44 |